DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

06998 EDDING GENOR

Closed Add to Porfolio
Index Constituent : None
Major Shareholders Ni Xin & Associates (32.78%)
OrbiMed Advisors LLC (10.80%)
Shen Nan Peng (8.14%)
Pink Crystal China Fund, L.P. (6.78%)
Hillhouse Investment Management, Ltd. (6.39%)		 Sector Health Care & Biotechnology
Web Site http://www.eddingpharm.com Tel N/A
Email pr@eddingpharm.com Fax N/A
Related Equities N/A
Principal Activities Principally focus on developing and commercializing oncology and autoimmune drugs in the People's Republic of China.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top